Advertisement Knome begins Early Access Program for knomeclinic - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Knome begins Early Access Program for knomeclinic

Knome said its knomeclinic, a software designed to help medical researchers and clinicians to understand human genomes for biological relevance, will start using early technology access program.

knomeclinic when upgraded to Early Access Program will have a robust, scalable, and extensible informatics and annotation platform,zkGAP, Desktop interpretation-support application, Knowledge database and Curation applications.

Knome chief executive officer Martin Tolar said, "With the launch of our early access program for knomeCLINIC, we are excited to begin collaborating with top-tier medical institutions in order to ensure that our software is optimized for the needs of clinical genomics and expectations of our initial partners."